Skip to content
6-K

Foreign Interim / Material

DOCEBO INC. DCBO

0001628280-25-024057

← back to feed
Filed
May 9, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted 2025 · Mar 31, 2025 30.26M sh
Shares Diluted 2024 · Mar 31, 2024 30.32M sh
Operating Cash Flow 2025 · Mar 31, 2025 $7.95M
Operating Cash Flow 2024 · Mar 31, 2024 $8.43M
Cash And Equivalents 2025 · Mar 31, 2025 $91.87M
Cash And Equivalents 2024 · Dec 31, 2024 $92.54M
Cash And Equivalents 2024 · Mar 31, 2024 $80.65M
Cash And Equivalents 2023 · Dec 31, 2023 $71.95M
Stockholders Equity 2025 · Mar 31, 2025 $52.43M
Stockholders Equity 2024 · Dec 31, 2024 $57.76M
Stockholders Equity 2024 · Mar 31, 2024 $59.64M
Stockholders Equity 2023 · Dec 31, 2023 $50.72M
Current Liabilities 2025 · Mar 31, 2025 $140.57M
Current Liabilities 2024 · Dec 31, 2024 $128.6M
Total Liabilities 2025 · Mar 31, 2025 $145.24M
Total Liabilities 2024 · Dec 31, 2024 $132.95M
Current Assets 2025 · Mar 31, 2025 $161.77M
Current Assets 2024 · Dec 31, 2024 $154.24M
Total Assets 2025 · Mar 31, 2025 $197.67M
Total Assets 2024 · Dec 31, 2024 $190.71M
Eps Diluted 2025 · Mar 31, 2025 $0.05
Eps Diluted 2024 · Mar 31, 2024 $0.17
Eps Basic 2025 · Mar 31, 2025 $0.05
Eps Basic 2024 · Mar 31, 2024 $0.17
Rd Expense 2025 · Mar 31, 2025 $13.4M
Rd Expense 2024 · Mar 31, 2024 $10.41M
Net Income 2025 · Mar 31, 2025 $1.47M
Net Income 2024 · Mar 31, 2024 $5.17M
Operating Income 2025 · Mar 31, 2025 $1.71M
Operating Income 2024 · Mar 31, 2024 $4.23M
Gross Profit 2025 · Mar 31, 2025 $45.9M
Gross Profit 2024 · Mar 31, 2024 $41.48M
Cost Of Revenue 2025 · Mar 31, 2025 $11.4M
Cost Of Revenue 2024 · Mar 31, 2024 $9.93M